Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 2,213

Document Document Title
WO/2010/059880A2
Compositions, devices, systems and methods for reducing and/or preventing photo-induced damage of one or more reactants in an illuminated analytical reaction by addition of one or more photo-induced damage mitigating agents to the reacti...  
WO/2010/059880A3
Compositions, devices, systems and methods for reducing and/or preventing photo-induced damage of one or more reactants in an illuminated analytical reaction by addition of one or more photo-induced damage mitigating agents to the reacti...  
WO/2010/054452A1
The invention belongs to the chemical pharmaceutical field, and the new compounds of the pterocarpanquinone family having formula (I) according to the invention can be reduction activated, generating alkylating species in the intracellul...  
WO/2010/035000A8
Using a combination of Kumada, Suzuki and Biellmann chemistry, various menaquinones can synthesised rapidly and with stereochemical integrity offering a new way of preparing these vitamin K2 components for the pharmaceutical market. In o...  
WO/2010/035000A1
Using a combination of Kumada, Suzuki and Biellmann chemistry, various menaquinones can synthesised rapidly and with stereochemical integrity offering a new way of preparing these vitamin K2 components for the pharmaceutical market. In o...  
WO/2010/034999A1
A compound of formula (I) in solid form, preferably crystalline form.  
WO/2010/023686A2
Disclosed herein discloses a crystalline form of 2-Chloro-3-[4-(4-chlorophenyl) cyclohexyl] [l,4]naphthoquinone and process for preparing the same and use thereof. The present invention also provides a process for producing 2-[4-(4- chlo...  
WO/2010/023686A3
Disclosed herein discloses a crystalline form of 2-Chloro-3-[4-(4-chlorophenyl) cyclohexyl] [l,4]naphthoquinone and process for preparing the same and use thereof. The present invention also provides a process for producing 2-[4-(4- chlo...  
WO/2010/009492A1
Atovaquone or a pharmaceutically acceptable salt thereof having a particle size diameter range with a D90 of between greater than 3 to about 10µm.  
WO/2010/001379A1
The invention provides novel intermediates of atovaquone and use thereof for the preparation of atovaquone  
WO/2010/002994A1
Novel compounds and compositions for treating patients in need of relief from HIV, AIDS, and AIDS-related diseases are described. Methods for treating HIV, AIDS, and AIDS-related diseases using the compounds described herein are also des...  
WO/2010/001378A1
Provided is a process for the epimerization of the cis isomer of atovaquone, atovaquone intermediates and isomeric mixtures thereof into their corresponding trans-isomers resulting in higher yield of pure atovaquone.  
WO/2009/158348A1
Methods of treating or suppressing oxidative stress disorders including mitochondrial diseases, impaired energy processing disorders, neurodegenerative diseases and diseases of aging are disclosed, as well as compounds useful in the meth...  
WO/2009/141562A2
The invention relates to quinones of formula (Ia) or (Ib), in which Formula (Ia) and Formula (Ib) R1 and R2 each independently represent - a hydrogen atom, - a C1-3O alkyl group in which one or more -CH2- linkages, apart from the attachm...  
WO/2009/141562A3
The invention relates to quinones of formula (Ia) or (Ib), in which Formula (Ia) and Formula (Ib) R1 and R2 each independently represent - a hydrogen atom, - a C1-3O alkyl group in which one or more -CH2- linkages, apart from the attachm...  
WO/2009/118443A1
The invention relates to oviedomycin derivatives, the method for obtaining same and the use thereof. The invention relates to oviedomycin derivatives obtained by fermentation of recombinant bacterial strains. The invention also relates t...  
WO/2009/118327A1
Derivatives of formula (I) wherein A is selected from the following rings: and their preparation and their application as antimalarial agents.  
WO/2009/098082A2
The present invention relates to naphthoquinone derivatives isolated from solid callus cultures from two species of the palaeotropical plant families Dioncophyllaceae and Ancistrocladaceae. It further relates to methods of their producti...  
WO/2009/098082A3
The present invention relates to naphthoquinone derivatives isolated from solid callus cultures from two species of the palaeotropical plant families Dioncophyllaceae and Ancistrocladaceae. It further relates to methods of their producti...  
WO/2009/068322A1
The present invention relates to compounds having a 1,4-benzoquinone or 1,4- benzoquinone imine scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds tog...  
WO/2009/063485A3
The present invention is related to the therapeutic uses of vitamin K, its analogues and derivatives in a diverse array of disease conditions. Vitamin K improves blood perfusion and ameliorates hypoxia in prevention and treatment of cond...  
WO/2009/016083A1
Disclosed are a method for improving the degradation of natural and/or synthetic polymers or a polymer article made from such polymer(s) by light and/or heat and/or humidity, comprising the incorporation of a compound of formula (I) into...  
WO/2009/007991A2
Disclosed herein is novel process for preparation of Atovaquone, which process includes reacting 1,4-naphthoquinone with trans-4-(4-chlorophenyl) cyclohexane carboxylic acid followed by halogenation to obtain dihalo-compound, further deh...  
WO/2009/007991A3
Disclosed herein is novel process for preparation of Atovaquone, which process includes reacting 1,4-naphthoquinone with trans-4-(4-chlorophenyl) cyclohexane carboxylic acid followed by halogenation to obtain dihalo-compound, further deh...  
WO/2009/004900A1
Disclosed are: an immunoadjuvant which has an excellent function of enhancing the production of an antibody and is highly safe; and a vaccine composition comprising the immunoadjuvant. More specifically disclosed are: an immunoadjuvant c...  
WO/2009/001367A2
The present invention relates to two novel and stable crystalline forms of atovaquone, to the processes for their preparation and to pharmaceutical compositions comprising them. The present invention also provides crystalline particles o...  
WO/2009/001367A3
The present invention relates to two novel and stable crystalline forms of atovaquone, to the processes for their preparation and to pharmaceutical compositions comprising them. The present invention also provides crystalline particles o...  
WO/2008/139290A1
The invention concerns a new process for the preparation of naphthoquinones, in particular an improved process for the preparation of 2,3-disubstituted 1,4- naphthoquinones, in the trans configuration.  
WO/2008/122988A1
Substantially pure atovaquone and parocess for the preparation thereof is disclosed.  
WO/2008/111515A1
Disclosed is a simple and highly efficient process for producing an aromatic carbonyl compound, which can produce an aromatic carbonyl compound having a substituent introduced to an aromatic ring adjacent to a carbonyl group. The process...  
WO/2008/107878A1
Novel cannabinoid-derived quinone derivatives (quinonoid derivatives) having a substituted hydroxyl group, pharmaceutical compositions comprising same and uses thereof as anti-proliferative agents, are provided.  
WO/2008/108105A1
A specific quinone compound, which contains two quinone groups at ortho positions and has such a characteristic that an electron transfer is caused during a reversible oxidation-reduction reaction, is oligomerized or polymerized. Consequ...  
WO/2007/129269A3
The present invention relates to an improved process for the preparation of Coenzyme Q. Coenzyme QlO or CoQlO has the chemical name 2- [(all -trans)- 3, 7,l l,15,19,23,27,31,35,39-decamethyl-2, 6, 10, 14, 18, 22, 26, 30, 34, 38 - tetraco...  
WO/2007/125919A1
Disclosed is a sulfonated polymer having excellent workability and excellent methanol resistance. More specifically, disclosed is an aromatic compound represented by the general formula (1): (1) wherein A, D and E independently represent...  
WO/2007/116750A1
Disclosed is a material for organic electroluminescent devices which contains a quinone derivative represented by one of the formulae (1)-(3) below. [In the formulae, R1-R16 respectively represent a hydrogen, a halogen, a cyano group, an...  
WO/2007/104242A1
The invention has disclosed 1,2,3-trihydroxy benzene and its derivatives or pharmaceutically acceptable salts of formula I for zinc ion metal-protease inhibition. These compounds are used for selective depressants of zinc ion metal-prote...  
WO/2007/078679A3
The present invention provides a convergent method for the synthesis of ubiquinones and ubiquinone analogues. Also provided are precursors of ubiquinones and their analogues that are useful in the methods of the invention. The invention ...  
WO/2007/078679A2
The present invention provides a convergent method for the synthesis of ubiquinones and ubiquinone analogues. Also provided are precursors of ubiquinones and their analogues that are useful in the methods of the invention. The invention ...  
WO/2007/073651A1
Disclosed are 4,5-seco abieta diterpene quinones (i.e. saproorthoquinone derivatives) of formula A, B or C, physiological acceptable salts, preparation process and pharmaceutical compositions thereof , wherein in formula A, R1 is CH3, CH...  
WO/2007/032378A1
A process for producing the compound represented by the following formula (1), which is menatetrenone. It is characterized in that a reaction solution consisting only of a solution obtained by dissolving the compound represented by the f...  
WO2002011563A8
A food supplement having prophylactic and-cancer effects, wherein the supplement comprises 20 to 99.99 % by weight of a product of biosynthesis by the productive microorganism Penicillium oxalicum var. Armeniaca CCM 8242, obtained by fer...  
WO/2007/026041A2
The invention relates to derivative 1,4-dioxaanthracene compounds, mainly 1,4-anthraquinoids, having formula I as tumour cell growth inhibitors. The invention also relates to methods of preparing said compounds, pharmaceutical compositio...  
WO/2007/026041A3
The invention relates to derivative 1,4-dioxaanthracene compounds, mainly 1,4-anthraquinoids, having formula I as tumour cell growth inhibitors. The invention also relates to methods of preparing said compounds, pharmaceutical compositio...  
WO/2007/017168A1
A process for the preparation of ubihydroquinones and ubiquinones by condensation of a prenol or isoprenol with a hydroquinone or derivative thereof in the presence of 0.005 - 1.0 mol% of a catalyst which is a Broensted-acid, a Lewis-aci...  
WO/2007/016762A1
The present invention relates to compounds which are perylenequinone derivatives, their stereoisomers and atropisomers. These compounds can be particularly useful as photosensitizers or sononsensitizers in photodynamic or sonodynamic the...  
WO/2007/016635A2
The present invention relates to methods for purifying Coenzyme Q10.  
WO/2007/004091A3
The present invention relates to novel intermediates for the preparation of coenzymes, processes for the preparation of the intermediates and an improved process for the preparation of Coenzymes. The present invention particularly relate...  
WO/2006/132348A1
It is intended to provide a method of purifying ubiquinone-10 characterized by separating and removing a structural analog of ubiquinone-10 contained in a raw material liquid containing ubiquinone-10 by using an acrylic porous cross-link...  
WO/2006/118167A1
[PROBLEMS] To provide a method, which can analyze environmental microorganisms in a simple and rapid manner, and an apparatus therefor. [MEANS FOR SOLVING PROBLEMS] An extractor for a quinone compound comprises an extraction vessel (9) i...  
WO/2006/104411A1
The invention relates to a method for producing 2-methyl-1,4-naphthoquinone by oxidising a 2-methyl-1-naphthol with the aid of oxygen or oxygen-containing gas in an organic solvent medium or in a 2-methyl-1-naphthol melt and intensively ...  

Matches 51 - 100 out of 2,213